John Wilkin
Stock Analyst at Craig-Hallum
(2.95)
# 1,592
Out of 5,056 analysts
5
Total ratings
80%
Success rate
34.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $8.47 | +41.68% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $13.71 | +9.41% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $39.28 | +14.56% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $7.48 | +6.95% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $6.66 | +335.44% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $8.47
Upside: +41.68%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $13.71
Upside: +9.41%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $39.28
Upside: +14.56%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $7.48
Upside: +6.95%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $6.66
Upside: +335.44%